CLINICAL SUPPLY MANAGEMENT ARTICLES
Can Your Operating Model Grow? Preparing Clinical Supply For What Comes Next
Having previously explained why early-stage biotechs should avoid overbuilding, Alicia Collins, of Tune Therapeutics, continues the discussion here in part 2, with thoughts on scaling clinical supply, selecting partners, and preparing for future constraints.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Interactive Response Technology (IRT) can transform site operations by replacing error-prone manual processes with real-time, automated systems that relieve some of the burden on trial sites.
-
Data is the single most important thing in a clinical trial. Leverage the power of clinical trial data with effective utilization and access in a changing regulatory landscape.
-
Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
-
Find out how advanced IRT systems now support diverse trial designs and how the expertise of RTSM vendors is crucial for tailoring solutions to trial needs and providing ongoing support.
-
DtP trials are a win-win for patients and sponsors. The purpose of this white paper is to provide in-depth information on the various DtP approaches while offering insight into best practices when incorporating DtP into the protocol.
-
Discover what happened when the Fountayn Platform, including RTSM, was used to support a client’s two-year, Phase III study seeking a cure for multiple sclerosis.
-
Explore the ways technology suppliers across the clinical trial space have begun investing in IRTs built around a microservices model capable of improving data access and visibility.